中文簡(jiǎn)介

該權(quán)威期刊的影響因子為1.818(根據(jù)最新的JCR/ISI影響因子排名編制)，始終如一地為一系列令人印象深刻的藥物代謝研究提供迫切需要的評(píng)論——涵蓋已建立的、新的和潛在的藥物;環(huán)境有毒化學(xué)物質(zhì);吸收;代謝和排泄;以及所有現(xiàn)存物種的酶學(xué)。此外，藥物代謝綜述為不同的醫(yī)學(xué)專業(yè)人員提供了新的假說，包括藥理學(xué)家、毒理學(xué)家、化學(xué)家、微生物學(xué)家、藥代動(dòng)力學(xué)家、免疫學(xué)家、質(zhì)譜學(xué)家以及從事異種生物轉(zhuǎn)化研究的酶學(xué)家。

投稿網(wǎng)址：https://mc.manuscriptcentral.com/ldmr

英文簡(jiǎn)介

With an impact factor of 1.818 (as compiled by the latest JCR/ISI Impact Factor Rankings), this authoritative journal consistently provides critically needed reviews of an impressive array of drug metabolism research —covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, Drug Metabolism Reviews offers new hypotheses of interest to diverse group of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well enzymologists working in xenobiotic biotransformation.